AKEBIA THERAPEUTICS, INC. AKBA Income Statement

Akebia therapeutics, inc. (AKBA)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13
Revenues:
Total revenues
350,813	335,001	325,296	286,488	234,478	207,742	238,451	226,565	206,292	181,227	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Cost of goods sold:
Product
105,391	108,935	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of intangibles
36,401	36,401	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total cost of goods sold
141,792	145,336	114,957	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating expenses:
Research and development
321,849	322,969	329,609	325,731	311,954	291,007	272,337	260,414	232,248	230,893	195,946	168,473	155,599	115,785	96,593	80,959	56,587	43,016	33,705	24,749	23,769	23,263	19,642	16,234	13,162	8,902	0	0	0
Selling, general and administrative
153,147	149,455	159,658	135,858	112,328	87,061	39,507	35,877	30,244	27,008	25,585	23,781	22,187	22,210	21,873	21,003	20,076	18,497	18,365	17,227	15,158	14,677	13,892	11,750	10,103	7,031	0	0	0
License expense
3,469	3,529	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
478,465	475,953	491,894	463,287	425,085	378,135	311,844	296,291	262,492	257,901	221,531	192,254	177,786	137,995	118,466	101,962	76,663	61,513	52,070	41,976	38,927	37,940	33,534	27,984	23,265	15,933	0	0	0
Operating loss
-269,444	-286,288	-281,555	-253,493	-229,632	-178,161	-73,393	-69,726	-56,200	-76,674	-129,328	-141,334	-155,386	-136,460	-118,466	-101,962	-76,663	-61,513	-52,070	-41,976	-38,927	-37,940	-33,534	-27,984	-23,265	-15,933	0	0	0
Other income (expense):
Interest income (expense)
-2,049	792	3,319	4,871	5,947	6,154	5,331	4,393	3,440	2,799	2,063	1,440	1,102	901	882	802	648	510	431	348	283	206	145	117	69	-704	0	0	0
Other income (expense)
-366	-794	-211	-10	-1	81	52	236	214	204	208	-337	-208	-188	-158	251	196	287	0	0	0	-	-	-	-	-	-	-	-
Net loss before income taxes
-271,859	-286,290	-278,447	-248,632	-223,686	-171,926	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Benefit from income taxes
-	-6,631	-33,217	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Extinguishment of debt and other liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,420	0	0	0
Reimbursements from Aerpio
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0
Net loss
-267,985	-279,659	-245,230	-216,692	-192,591	-143,588	-68,010	-65,097	-52,546	-73,671	-127,057	-140,231	-154,492	-135,747	-117,742	-100,909	-75,819	-60,716	-51,230	-41,103	-38,032	-37,034	-32,610	-27,030	-22,243	-13,167	0	0	0
Accretion on preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	86,899	89,923	92,672	141,937	55,886	0	0	0
Net loss applicable to common stockholders - basic and diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-123,933	-122,535	-119,703	-164,180	-69,053	0	0	0
Net loss per share - basic and diluted
-0.47	-0.79	-0.46	-0.49	-0.62	-0.87	-0.46	-0.60	-0.48	0.48	-0.49	-0.53	-1.15	-0.99	-0.96	-0.95	-0.70	-0.68	-0.68	-0.40	-0.53	36.19	-0.47	-0.39	-43.37	-8.74	-11.92	-103.19	-3.09
Weighted-average number of common shares - basic and diluted
128,395	119,358	118,863	118,268	117,063	69,404	57,027	56,890	48,613	47,485	46,938	40,819	38,759	38,285	37,897	37,811	36,873	30,447	28,784	26,614	20,030	20,055	19,691	19,652	2,227	648	546	504	475
Comprehensive loss:
Net loss and comprehensive loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Net loss
-267,985	-279,659	-245,230	-216,692	-192,591	-143,588	-68,010	-65,097	-52,546	-73,671	-127,057	-140,231	-154,492	-135,747	-117,742	-100,909	-75,819	-60,716	-51,230	-41,103	-38,032	-37,034	-32,610	-27,030	-22,243	-13,167	0	0	0
Other comprehensive gain - unrealized gain on debt securities
-	261	415	482	514	181	-186	-163	-329	-400	-216	-333	-195	-42	-234	-170	-252	-234	-50	-78	0	-	0	0	-	-	-	-	-
Total comprehensive loss
-267,949	-279,398	-244,815	-216,210	-192,077	-143,407	-68,196	-65,260	-52,875	-74,071	-127,273	-140,564	-154,687	-135,789	-117,976	-101,079	-76,071	-60,950	-51,242	-41,178	-38,096	-37,090	-30,482	-23,921	0	-	0	0	-
Product Revenue, Net
Total revenues
117,208	111,108	89,017	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
License, Collaboration and Other Revenue
Total revenues
233,596	223,882	236,268	227,464	204,543	200,918	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-